- Home
- BBIO vs APTV Comparison
BBIO vs APTV Comparison
Compare BBIO & APTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BBIO | APTV |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.2B | 12.6B |
| IPO Year | 2019 | 2011 |
Fundamental Metrics
Financial Performance| Metric | BBIO | APTV |
|---|---|---|
| Price | $69.21 | $60.75 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 25 | 17 |
| Target Price | $86.33 | ★ $88.80 |
| AVG Volume (30 Days) | 2.3M | ★ 2.4M |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.75 |
| Revenue | $502,076,000.00 | ★ $20,398,000,000.00 |
| Revenue This Year | $89.45 | $7.40 |
| Revenue Next Year | $73.78 | $4.87 |
| P/E Ratio | ★ N/A | $80.52 |
| Revenue Growth | ★ 126.26 | 3.47 |
| 52 Week Low | $31.77 | $56.56 |
| 52 Week High | $84.94 | $88.93 |
Technical Indicators
Market Signals| Indicator | BBIO | APTV |
|---|---|---|
| Relative Strength Index (RSI) | 40.28 | 43.08 |
| Support Level | $61.95 | $57.16 |
| Resistance Level | $78.96 | $62.43 |
| Average True Range (ATR) | 3.93 | 1.66 |
| MACD | -0.87 | 0.54 |
| Stochastic Oscillator | 4.38 | 65.93 |
Price Performance
Historical ComparisonAbout BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About APTV Aptiv PLC
Aptiv PLC is an industrial technology company focused on enabling a more automated, electrified and digitalized future. The company's technologies reach from sensor to cloud, including the hardware and software necessary to support automotive and other industries on a global basis. Its Advanced Safety and User Experience segment provides advanced software and services, intelligent sensors and high-performance compute platforms; its Engineered Components Group segment provides connection systems, high-performance interconnects, and cable management and protection solutions; and its Electrical Distribution Systems segment provides low voltage and high voltage power, signal and data distribution.